JMP Securities downgraded Marinus Pharmaceuticals (MRNS) to Market Perform from Outperform.
Don't Miss Our Christmas Offers:
- Discover the latest stocks recommended by top Wall Street analysts, all in one place with Analyst Top Stocks
- Make smarter investments with weekly expert stock picks from the Smart Investor Newsletter
Published first on TheFly – the ultimate source for real-time, market-moving breaking financial news. Try Now>>
Read More on MRNS:
- Marinus Pharmaceuticals downgraded to Hold from Buy at Truist
- Marinus notes TrustTSC trial misses primary endpoint, to evaluate alternatives
- Marinus Pharmaceuticals presents clinical data from pivotal phase 3 RAISE trial
- Biotech Alert: Searches spiking for these stocks today
- Microsoft downgraded, Pinterest initiated: Wall Street’s top analyst calls